4//SEC Filing
JOULWAN GEORGE A 4
Accession 0001140361-17-041866
CIK 0001367644other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 4:57 PM ET
Size
13.3 KB
Accession
0001140361-17-041866
Insider Transaction Report
Form 4
JOULWAN GEORGE A
Director
Transactions
- Sale
Common Stock
2017-11-07$41.24/sh−3,946$162,733→ 30,377 total - Exercise/Conversion
Common Stock
2017-11-07$15.97/sh+3,946$63,018→ 34,323 total - Exercise/Conversion
Common Stock
2017-11-07$18.64/sh+10,305$192,085→ 40,682 total - Exercise/Conversion
Employee Stock Option (Right to buy)
2017-11-07−3,946→ 0 totalExercise: $15.97Exp: 2020-07-17→ Common Stock (3,946 underlying) - Sale
Common Stock
2017-11-07$41.24/sh−10,305$424,978→ 30,377 total - Exercise/Conversion
Employee Stock Option (Right to buy)
2017-11-07−10,305→ 0 totalExercise: $18.64Exp: 2021-05-22→ Common Stock (10,305 underlying)
Footnotes (3)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.45, inclusive.
- [F2]Consists of an option granted under the company's stock incentive plan as amended and restated.
- [F3]The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.
Documents
Issuer
Emergent BioSolutions Inc.
CIK 0001367644
Entity typeother
Related Parties
1- filerCIK 0001222197
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 4:57 PM ET
- Size
- 13.3 KB